Rosa Castro

May 31, 2023 | epha.org | Rosa Castro

by Rosa Castro | May 31, 2023 | Opinion Will transparency of R&D costs lead to more affordable medicines?

Feb 9, 2023 | thelancet.com | Christine Årdal |Enrico Baraldi |Reinhard Busse |Rosa Castro

To prevent the development of resistance, new antibiotics are used as last resort treatments and, if properly used, have small patient populations, resulting in fairly low sales revenues for industry. As antibiotic resistance increases globally, antibiotic innovation is struggling.